Insider Transactions in Q4 2023 at Y M Abs Therapeutics, Inc. (YMAB)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2023
|
Thomas Gad CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+26.25%
|
$100,000
$2.0 P/Share
|
|
Dec 15
2023
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
50,000
-15.87%
|
$300,000
$6.61 P/Share
|
|
Dec 14
2023
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
50,000
-13.7%
|
$300,000
$6.83 P/Share
|
|
Dec 13
2023
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
50,000
-12.05%
|
$300,000
$6.58 P/Share
|
|
Dec 11
2023
|
Johan Wedell Wedellsborg Director |
BUY
Open market or private purchase
|
Indirect |
109,318
+1.18%
|
$655,908
$6.93 P/Share
|
|
Dec 11
2023
|
Biotech Ap S Wg Director |
BUY
Open market or private purchase
|
Direct |
109,318
+1.18%
|
$655,908
$6.93 P/Share
|
|
Dec 08
2023
|
Johan Wedell Wedellsborg Director |
BUY
Open market or private purchase
|
Indirect |
18,503
+0.41%
|
$111,018
$6.99 P/Share
|
|
Dec 08
2023
|
Biotech Ap S Wg Director |
BUY
Open market or private purchase
|
Direct |
18,503
+0.41%
|
$111,018
$6.99 P/Share
|
|
Dec 07
2023
|
Johan Wedell Wedellsborg Director |
BUY
Open market or private purchase
|
Indirect |
6,183
+0.14%
|
$37,098
$6.5 P/Share
|
|
Dec 07
2023
|
Biotech Ap S Wg Director |
BUY
Open market or private purchase
|
Direct |
6,183
+0.14%
|
$37,098
$6.5 P/Share
|
|
Nov 29
2023
|
Johan Wedell Wedellsborg Director |
BUY
Open market or private purchase
|
Indirect |
51,837
+1.16%
|
$259,185
$5.97 P/Share
|
|
Nov 29
2023
|
Biotech Ap S Wg Director |
BUY
Open market or private purchase
|
Direct |
51,837
+1.16%
|
$259,185
$5.97 P/Share
|
|
Nov 28
2023
|
Biotech Ap S Wg Director |
BUY
Open market or private purchase
|
Direct |
30,671
+0.7%
|
$153,355
$5.81 P/Share
|
|
Nov 28
2023
|
Johan Wedell Wedellsborg Director |
BUY
Open market or private purchase
|
Indirect |
30,671
+0.7%
|
$153,355
$5.81 P/Share
|
|
Nov 27
2023
|
Biotech Ap S Wg Director |
BUY
Open market or private purchase
|
Direct |
62,516
+1.42%
|
$312,580
$5.49 P/Share
|
|
Nov 27
2023
|
Johan Wedell Wedellsborg Director |
BUY
Open market or private purchase
|
Indirect |
62,516
+1.42%
|
$312,580
$5.49 P/Share
|
|
Nov 21
2023
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
75,000
-15.31%
|
$375,000
$5.31 P/Share
|
|
Nov 20
2023
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
75,000
-13.27%
|
$375,000
$5.3 P/Share
|